Larry Anderson, MD, PhD

Assistant Professor
Internal Medicine

Contact Information

UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390

larry.anderson@utsouthwestern.edu

To make an appointment, call 214-645-8300.

Education

FellowshipFred Hutchinson Cancer Research Center, Medical Oncology (2006)
InternshipMayo Clinic, Internal Medicine (2003)
Medical SchoolUniversity of Texas Medical School at Houston (2000)

Research Interests

Cancer immunology
Immunotherapy
MAGE-C1 (CT-7)
Multiple Myeloma
Stem Cell Transplantation

Publications

Featured
Ganciclovir chemoablation of herpes simplex thymidine kinase suicide gene-modified tumors produces tumor necroses and induces systemic immune responses.

Mullen CA, Anderson L, Woods K, Nishino M, and Petropoulos D , Human Gene Therapy , September 1998; (1998):2019-2030

Featured
Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.

Anderson LD Jr, Mori S, Mann S, Savary CA, and Mullen CA , Cancer Research , October 2000; (60):5797-5802

Featured
Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine

Anderson LD Jr, Petropoulos D, Everse LA, and Mullen CA , Cancer Research , October 1999; (59):1525-1530

Featured
HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells.

Anderson LD Jr, Hudson JM, Savary CA, Fisk B, Gershenson DM, and Ioannides CG , Cancer Immunology Immunotherapy , October 1999; (48):401-410

Featured
Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate graft-versus-host disease and increases peri-BMT mortality.

Everse LA, Anderson LD Jr, Rooijen N van, and Mullen CA , Transplantation , March 2001; (71):611-618

Featured
Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease

Anderson LD Jr, Savary CA, and CA Mullen , Blood , April 2000; (95):2426-2433

Use of Gene-Modified T-cells as Antigen Presenting Cells (T-APC) for Vaccination against Myeloma Antigens.

Anderson LD Jr, Cook DR, Berger C, Maloney D, and Riddell SR , Blood , November 2007; (110):Abstract #2758

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) for Refractory Waldenstrom s Macroglobulinemia (WM): Evidence for a Graft-Versus-WM Effect.

Anderson LD Jr, Sandmaier BM, Maris MB, et al , Blood , November 2006; (108):Abstract #3034

DNA Immunization against the cerebral self antigen Amyloid beta 42 has high potential as safe therapy for Alzheimer’s Disease

Lambracht-Washington D, Qu B, Fu M, Anderson LD Jr, Stuve O, Eager TN, and Rosenberg RN , Cellular and Molecular Neurobiology , 2011; ((In Press))

Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of Multiple Myeloma

Anderson LD Jr, Cook DR, Yamamoto T, Berger C, Maloney DG, and Riddell SR , Cancer Immunology Immunotherapy , 2011; ((In Press))

Honors/Awards

ACS Institutional Research Grant

Research Grant (2010)

ASCO Young Investigator Award

Research Grant (2006)

K12 Career Development Award

Research Grant (2006)

Multiple Myeloma Research Foundation Fellow Award

Research Grant (2006)

Professional Associations/Affiliations

American Society of Hematology